Hepatitis
Infectious Disease·MeSH: Hepatitis, Alcoholic
Prevalence
5000.0 / 100K
Incidence
500.0 / 100K/yr
166 drugs in development·73 companies·1 clinical trial
Drug Pipeline by Phase
Approved(12)
Phase 3(27)
Phase 2(65)
Phase 1(41)
Preclinical(10)
Unknown(2)
BLA Filed(1)
| Drug | Company |
|---|---|
| bulevirtide | GILEAD SCIENCES, INC. (GILD) |
Phase 1/Phase 2(4)
Compare drugs
Frequently asked questions
How many drugs are in development for Hepatitis?
BioSniper tracks 166 drugs in development for Hepatitis across 73 companies.
How many clinical trials target Hepatitis?
There are 1 clinical trial targeting Hepatitis tracked by BioSniper.
What is the prevalence of Hepatitis?
The estimated prevalence of Hepatitis is approximately 5000.0 per 100,000 population.
Deep-dive into Hepatitis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis